泰国处方者对直接口服抗凝药标签的依从性及其对结局的影响
该回顾性研究纳入泰国10家三级医院2013-2017年使用DOAC≥6个月的成人患者1200例,评估处方者对获批标签的依从性及剂量偏差对临床结局的影响。结果显示适应症依从性高(94.2%),但仅67.1%剂量完全符合标签;低剂量增加血栓栓塞风险,高剂量增加出血风险。
要点
- 仅67.1%的DOAC处方剂量与获批标签一致,低剂量和高剂量分别占21.9%和10.7%。
核心结论
- 处方者对DOAC获批适应症的依从性高(94.2%),但约1/3处方剂量与标签不一致。
- 剂量偏差(低剂量或高剂量)与不良临床结局风险增加相关。
研究设计与样本
- 回顾性研究,采用简单分层随机抽样,纳入泰国10家三级医院2013-2017年使用DOAC≥6个月的成人患者1200例。
- 根据泰国FDA获批标签将患者分为获批剂量、低剂量和高剂量三组,采用Cox比例风险模型评估剂量对血栓栓塞和出血事件的影响。
主要发现
- 1200例中,1130例(94.2%)处方符合获批适应症,70例(5.8%)存在禁忌症或超说明书使用。
- 1026例剂量评估队列中,688例(67.1%)使用获批剂量,227例(21.9%)低剂量,110例(10.7%)高剂量。
临床怎么用
- 临床药师应核对DOAC处方剂量与获批标签的一致性,尤其关注低剂量和高剂量偏差。
- 对低剂量DOAC患者需评估血栓栓塞风险,对高剂量患者需警惕出血风险。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
- 研究仅基于泰国10家三级医院的数据,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study aimed to evaluate the prescriber compliance to the approved labels of direct oral anticoagulants (DOACs) and impact of appropriateness of dosing on clinical outcomes. METHODS: A retrospective study was conducted using simple-stratified random sampling of adult patients receiving ≥6 months of DOACs for various indications during 2013-2017 in 10 tertiary care hospitals. Patients were classified into 3 dosing groups including approved dose, underdosing and overdosing based on the Thai Food and Drug Administration-approved labels. Cox proportional hazard models were used to evaluate the impact of different dosings on thromboembolic and bleeding events. RESULTS: From 1200 patients included in the data analysis, prescribing of DOACs was consistent with the approved indications in 1130 cases (94.2%) while 70 patients (5.8%) received DOACs despite having contraindications or with off-label usage. Among 1026 cases of dosing evaluation cohort, 688 patients (67.1%) received approved doses. There were 227 (21.9%) and 110 (10.7%) cases of underdosing and overdosing, respectively. Multivariate analysis showed that underdosing was associated with an increased risk of thromboembolism 3.023 (95% confidence interval [CI]: 1.291-7.080; P = .011) while overdosing was associated with an increased risk of bleeding requiring hospitalization (adjusted hazard ratio, 3.045; 95% CI, 1.501-6.178; P = .002) and Bleeding Academic Research Consortium type 2 or more (adjusted hazard ratio, 2.196; 95% CI, 1.083-4.452; P = .029). CONCLUSION: Prescribers' compliance to approved indications were high. However, 1/3 of DOAC prescriptions were inconsistent with approved dosing. Dosing deviation was associated with an increase in adverse clinical outcomes.
引用
- Wattanaruengchai P, Nathisuwan S, Rattanavipanon W, et al. Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand. Br J Clin Pharmacol. 2020. PMID: 32857417. doi:10.1111/bcp.14535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。